Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Antonelli

Showing results (621-630 of 858) with videos related to

Pageof 86
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
Indian Journal of Surgical Oncology|January 23, 2023
American Society of Anesthesiologists' (ASA) Physical Status System and Risk of Major Clavien-Dindo Complications After Robot-Assisted Radical Prostatectomy at Hospital Discharge: Analysis of 1143 Consecutive Prostate Cancer PatientsAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
Journal of Robotic Surgery|June 16, 2021
Severe intraoperative bleeding predicts the risk of perioperative blood transfusion after robot-assisted radical prostatectomyAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
Clinical Genitourinary Cancer|December 3, 2014
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian ProjectRiccardo Schiavina, Sergio Serni, Andrea Mari, et al.
International Urology and Nephrology|July 2, 2020
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissectionAlessandro Tafuri, Nelia Amigoni, Riccardo Rizzetto, et al.
European Urology|September 18, 2025
Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic ObstructionAntonio Franco, Francesco Ditonno, Celeste Manfredi, et al.
Journal of Robotic Surgery|March 23, 2024
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factorsAntonio Benito Porcaro, Rossella Orlando, Andrea Panunzio, et al.
Urology|April 26, 2024
Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based StudyFrancesco Ditonno, Antonio Franco, Celeste Manfredi, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
Pageof 86

Showing results (621-630 of 858) with videos related to

Sort By:
Pageof 86
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
Indian Journal of Surgical Oncology|January 23, 2023
American Society of Anesthesiologists' (ASA) Physical Status System and Risk of Major Clavien-Dindo Complications After Robot-Assisted Radical Prostatectomy at Hospital Discharge: Analysis of 1143 Consecutive Prostate Cancer PatientsAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
Journal of Robotic Surgery|June 16, 2021
Severe intraoperative bleeding predicts the risk of perioperative blood transfusion after robot-assisted radical prostatectomyAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
Clinical Genitourinary Cancer|December 3, 2014
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian ProjectRiccardo Schiavina, Sergio Serni, Andrea Mari, et al.
International Urology and Nephrology|July 2, 2020
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissectionAlessandro Tafuri, Nelia Amigoni, Riccardo Rizzetto, et al.
European Urology|September 18, 2025
Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic ObstructionAntonio Franco, Francesco Ditonno, Celeste Manfredi, et al.
Journal of Robotic Surgery|March 23, 2024
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factorsAntonio Benito Porcaro, Rossella Orlando, Andrea Panunzio, et al.
Urology|April 26, 2024
Trends and Costs of Minimally Invasive Surgery for Kidney Cancer in the US: A Population-based StudyFrancesco Ditonno, Antonio Franco, Celeste Manfredi, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
Pageof 86